- Home
- STAA
as 06-20-2025 4:00pm EST
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | MONROVIA |
| Market Cap: | 850.4M | IPO Year: | N/A |
| Target Price: | $27.17 | AVG Volume (30 days): | 780.5K |
| Analyst Decision: | Hold | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.50 - $49.86 | Next Earning Date: | 08-06-2025 |
| Revenue: | $279,134,000 | Revenue Growth: | -14.44% |
| Revenue Growth (this year): | -16.86% | Revenue Growth (next year): | 29.34% |
Stock Insider Trading Activity of STAAR Surgical Company (STAA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Apr 8 '25 | Buy | $7.69 | 187,227 | $2,866,428.46 | 13,498,791 | |
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Apr 3 '25 | Buy | $8.09 | 845,220 | $13,627,504.30 | 13,498,791 | |
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Mar 31 '25 | Buy | $8.72 | 53,969 | $941,285.43 | 13,498,791 | |
| BROADWOOD PARTNERS, L.P. | STAA | 10% Owner | Mar 26 '25 | Buy | $8.74 | 113,384 | $1,983,823.65 | 13,498,791 |
Latest STAAR Surgical Company News
STAA Breaking Stock News: Dive into STAA Ticker-Specific Updates for Smart Investing
StockStory
3 days ago
Q1 Earnings Roundup: STAAR Surgical (NASDAQ:STAA) And The Rest Of The Medical Devices & Supplies - Specialty Segment
StockStory
10 days ago
STAA Q1 Earnings Call: Tariff Mitigation, Cost Cuts, and China Inventory Reshape Outlook
StockStory
10 days ago
3 Small-Cap Stocks with Mounting Challenges
Argus Research
10 days ago
STAA: Rating decreased to a SELL
StockStory
22 days ago
3 Stocks Under $50 with Mounting Challenges
StockStory
25 days ago
1 Cash-Heavy Stock Worth Your Attention and 2 to Steer Clear Of
Simply Wall St.
a month ago
3 Stocks That Could Be Priced Below Their Fair Value Estimates In May 2025
Business Wire
a month ago
STAAR Surgical Announces Participation in Upcoming Investor Conferences
Compare STAA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STAA STAAR Surgical Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.